In the SURMOUNT trials for tirzepatide, researchers used an escalation starting at 2.5 mg weekly, increasing by 2.5 mg every four weeks until reaching the target maintenance dose (typically 5 mg, 10 mg, or 15 mg)
*Correspondence: Yi Hua, [email protected] This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Little research has yet been conducted on epitalon by researchers without ties to Russian institutions, so it may be too soon to make definitive statements about epitalon, but the findings so far certainly give a justification for further investigation
Follow any personalized post-treatment instructions provided
Disulfide bonds between cysteine residues in peptide chains contribute to the 3D structure of proteins
8 weeks 8 syringes 1 syringe per weekly injection
